Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

What's new in Guillain-Barré syndrome in 2007-2008?

Journal of the peripheral nervous system : JPNS - 1 Jun 2009

van Doorn Pieter A

Abstract excerpt

The years 2007 and early 2008 have been an exciting time for Guillain-Barré syndrome (GBS) research. Epidemiological studies have shown that the incidence of GBS remains stable at about 2/100,000 per year but that there have been changes in hospitalization use, likely due to the widespread availability of IVIg. Research into mechanisms has shown the importance of single amino acids in Campylobacter jejuni and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Monoclonal, Humanized
Share to Campylobacter jejuni

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Guillain-Barre Syndrome

Share to Immunologic Factors

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Source

Identifiers

PMID: 19691528
DOI: 10.1111/j.1529-8027.2009.00215.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

What's new in Guillain-Barré syndrome in 2007-2008?PMID 19691528Read ↗

Triggers of Guillain–Barré Syndrome: Campylobacter jejuni PredominatesSemantic proximity Read ↗

The immunobiology of Guillain‐Barré syndromesSemantic proximity Read ↗

Antiganglioside antibodies and their pathophysiological effects on Guillain-Barre syndrome and related disorders--A reviewSemantic proximity Read ↗

Guillain–Barré syndrome and anti-ganglioside antibodies: a clinician-scientist’s journeySemantic proximity Read ↗

The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndromeSemantic proximity Read ↗

The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome.Semantic proximity Read ↗

Ganglioside mimicry as a cause of Guillain–Barré syndromeSemantic proximity Read ↗

Guillain–Barré SyndromeSemantic proximity Read ↗

Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain-Barré syndrome.Semantic proximity Read ↗

Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.Semantic proximity Read ↗

Serum antibodies to GM1, GD1b, peripheral nerve myelin, and <i>Campylobacter jejuni</i> in patients with Guillain‐Barré syndrome and controls: Correlation and prognosisSemantic proximity Read ↗

Axonal degeneration induced by intraneural injection of Campylobacter jejuni antiserum containing high titer anti-GM1 antibody.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.